Literature DB >> 8148422

Trisomy 21 as the sole clonal aberration in a patient with acute myelomonocytic leukemia with abnormal bone marrow eosinophils and extramedullary involvement.

R Dengler1, J U Walther, B Emmerich.   

Abstract

We describe a 30-year-old acute myelomonocytic leukemia patient with abnormal bone marrow eosinophils (AML FAB subtype M4Eo) with extensive extramedullary involvement and, in the abscence of an aberration involving chromosome 16, clonal trisomy 21 in the leukemic blast cells.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8148422     DOI： 10.1007/bf01715140

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


  13 in total

1.  Rapid detection of chromosome 16 inversion in acute nonlymphocytic leukemia, subtype M4: regional localization of the breakpoint in 16p.

Authors:  J G Dauwerse; T Kievits; G C Beverstock; D van der Keur; E Smit; H W Wessels; A Hagemeijer; P L Pearson; G J van Ommen; M H Breuning
Journal:  Cytogenet Cell Genet       Date:  1990

2.  Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemia.

Authors:  C A Schiffer; E J Lee; T Tomiyasu; P H Wiernik; J R Testa
Journal:  Blood       Date:  1989-01       Impact factor: 22.113

3.  Morphologic, immunologic, and cytogenetic (MIC) working classification of the acute myeloid leukemias. Report of the Workshop held in Leuven, Belgium, September 15-17, 1986. Second MIC Cooperative Study Group.

Authors: 
Journal:  Cancer Genet Cytogenet       Date:  1988-01

4.  Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Ann Intern Med       Date:  1985-10       Impact factor: 25.391

5.  Detection of karyotypic abnormalities in most patients with acute nonlymphocytic leukemia by adding ethidium bromide to short-term cultures.

Authors:  S Misawa; H Yashige; S Horiike; M Taniwaki; H Nishigaki; T Okuda; S Yokota; S Tsuda; J Edagawa; H Imanishi
Journal:  Leuk Res       Date:  1988       Impact factor: 3.156

6.  Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO)

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1991-07       Impact factor: 6.998

7.  Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative Group.

Authors:  T Büchner; D Urbanitz; W Hiddemann; H Rühl; W D Ludwig; J Fischer; H C Aul; H A Vaupel; R Kuse; G Zeile
Journal:  J Clin Oncol       Date:  1985-12       Impact factor: 44.544

8.  Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia.

Authors:  P Liu; S A Tarlé; A Hajra; D F Claxton; P Marlton; M Freedman; M J Siciliano; F S Collins
Journal:  Science       Date:  1993-08-20       Impact factor: 47.728

9.  Cytogenetic studies on acute myelomonocytic leukaemia (M4) with eosinophilia.

Authors:  R Berger; A Bernheim; M T Daniel; F Valensi; F Sigaux; G Flandrin
Journal:  Leuk Res       Date:  1985       Impact factor: 3.156

10.  Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosis.

Authors:  R A Larson; S F Williams; M M Le Beau; M A Bitter; J W Vardiman; J D Rowley
Journal:  Blood       Date:  1986-12       Impact factor: 22.113
View more
  1 in total

1.  Biological and clinical features of trisomy 21 in adult patients with acute myeloid leukemia.

Authors:  Paolo Strati; Naval Daver; Farhad Ravandi; Naveen Pemmaraju; Sherry Pierce; Guillermo Garcia-Manero; Aziz Nazha; Tapan Kadia; Elias Jabbour; Gautam Borthakur; Stefan Faderl; Alfonso Quintas-Cardama; Hagop Kantarjian; Jorge Cortes
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2013-08-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.